Trust Company’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$158K Sell
6,523
-415
-6% -$10K 0.01% 187
2026
Q1
$168K Buy
6,938
+24
+0.3% +$583 0.02% 188
2025
Q4
$168K Sell
6,914
-1,394
-17% -$33.9K 0.02% 187
2025
Q3
$202K Hold
8,308
0.02% 142
2025
Q2
$202K Sell
8,308
-1
-0% -$24 0.02% 144
2025
Q1
$201K Buy
8,309
+1,043
+14% +$25.1K 0.02% 146
2024
Q4
$174K Buy
7,266
+5,170
+247% +$124K 0.02% 146
2024
Q3
$51.1K Hold
2,096
0.01% 198
2024
Q2
$49.7K Hold
2,096
0.01% 186
2024
Q1
$49.9K Buy
+2,096
New +$49.9K 0.01% 182

Other funds holding IBDS

Trust Company's IBDS Position: Q2 2026 in Review

Trust Company reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 6% in Q2 2026, selling an estimated $10K and leaving 6,523 shares worth $158K. The position accounts for 0.01% of the portfolio, ranked #187.

Trust Company first reported a position in IBDS in Q1 2024 and has held it in 10 quarters since. The position peaked at $202K in Q3 2025. 76 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • Trust Company held 6,523 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $158K as of Q2 2026.
  • Trust Company sold 415 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $10K.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.01% of Trust Company's portfolio in Q2 2026, its #187 holding.
  • Trust Company first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • Trust Company's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $202K in Q3 2025.
  • 76 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.